美國臨床實驗試驗供應和物流市場：市場規模、佔有率和趨勢分析（按服務、階段、治療領域和最終用途分類），細分市場預測（2025-2033 年）

美國臨床實驗試驗供應與物流市場摘要

據估計，美國臨床實驗試驗供應和物流市場在 2024 年的價值為 14 億美元，預計到 2033 年將達到 28.7 億美元，2025 年至 2033 年的複合年成長率為 8.45%。

受腫瘤學、罕見疾病、細胞和基因治療等創新治療領域的研發活動的推動，市場正經歷強勁成長。

此外，日益複雜的臨床試驗設計以及對病人安全和產品完整性日益嚴格的監管要求，都對複雜的供應鏈模式提出了更高的要求。同時，分散式臨床臨床實驗和直接面向患者的運輸方案的採用，凸顯了靈活合規的物流網路的重要性。此外，製藥和生物技術公司不斷增加的投資，也推動了對高效包裝、溫控儲存和物流服務的需求，這些對於及時進行臨床試驗至關重要。

此外，大多數臨床臨床實驗（涵蓋各個階段）都得到了專業供應解決方案的支持，包括低溫運輸物流、對照藥物採購、臨床包裝和退貨管理。早期臨床試驗透過靈活的供應模式，有效管理時間緊迫的小批量藥物分發；而大規模的III期臨床試驗則受益於完善的全球倉儲網路。此外，生技藥品、生物相似藥和先進療法的研發管線不斷擴展，進一步推動了對超低溫處理和專業運輸解決方案的需求。隨著臨床實驗規模和地理範圍的擴大，供應和物流供應商在確保臨床實驗藥物的持續供應方面發揮著至關重要的作用。他們透過最大限度地減少延誤、確保合規性並提高試驗效率，在促進市場擴張方面發揮著不可或缺的作用。

此外，現有市場參與企業正積極推行策略性舉措，例如收購、拓展服務以及投資數位化平台，以提高透明度和追蹤能力。與申辦者和合約委外研發機構(CRO) 的合作也在加速推進，各公司正致力於擴大在美國的低溫運輸能，以應對臨床實驗日益複雜化帶來的挑戰。預計這些因素將在預測期內推動市場成長。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章美國臨床實驗試驗供應與物流市場：促進因素、趨勢與範圍

• 市場關聯性展望
  • 母市場展望
  • 相關/附隨市場展望
• 市場動態
  • 市場促進因素分析
  • 市場限制因素分析
  • 市場挑戰
  • 市場機遇
• 科技情勢
• 定價模式分析
• 研發支出分析（2018-2024）
• 臨床實驗數量分析（2024 年）
• 關稅影響分析
• 價值鏈分析
  • 供應趨勢
  • 需求趨勢
• 市場分析工具
  • 波特五力分析
  • PESTEL分析與SWOT分析
  • 新冠疫情影響分析

第4章：美國臨床實驗試驗供應與物流市場：按服務類型分類的估算與趨勢分析

• 美國臨床實驗試驗供應與物流市場：細分儀表板（按服務分類）
• 美國臨床實驗試驗供應與物流市場：按服務類型分類的變化分析
• 依服務年資（2021-2033）
• 物流與配送
• 儲存/保留
• 包裝、標籤和匿名化
• 製造業
• 比較採購
• 其他服務

第5章：美國臨床實驗試驗供應與物流市場：依階段分類的估算與趨勢分析

• 美國臨床實驗試驗供應與物流市場：細分儀表板（按階段分類）
• 美國臨床實驗試驗供應與物流市場：按階段分類的銷售分析
• 愛別 (2021-2033)
• 第一階段
• 第二階段
• 第三階段
• 第四階段

第6章美國臨床實驗試驗供應和物流市場：按治療領域分類的估計和趨勢分析

• 美國臨床實驗試驗供應與物流市場：按治療領域細分儀表板
• 美國臨床實驗試驗供應與物流市場：按治療領域分類的銷售分析
• 依治療領域分類（2021-2033 年）
• 瘤
• 心血管疾病
• 呼吸系統疾病
• 中樞神經系統和精神障礙
• 其他

第7章美國臨床實驗試驗供應與物流市場：依最終用途分類的估算與趨勢分析

• 美國臨床實驗試驗供應與物流市場：細分儀表板，依最終用途分類
• 美國臨床實驗試驗供應和物流市場：按最終用途分類的銷售分析
• 依最終用途分類（2021-2033 年）
• 製藥
• 生技藥品
• 醫療設備

第8章 競爭情勢

• 參與企業
• 市場分析（熱力圖分析，2024 年）
• 公司簡介
  • Thermo Fisher Scientific Inc.
  • UPS Healthcare
  • Piramal Pharma Solutions
  • DHL
  • Parexel International
  • Almac Group
  • UDG Healthcare
  • FedEx
  • Catalent, Inc.

U.S. Clinical Trials Supply & Logistics Market Summary

The U.S. clinical trials supply and logistics market size was estimated at USD 1.40 billion in 2024 and is projected to reach USD 2.87 billion by 2033, growing at a CAGR of 8.45% from 2025 to 2033. The market has experienced robust growth driven by research and development activities for innovative therapeutic areas such as oncology, rare diseases, and cell and gene therapies.

Besides, the growing complexity of trial designs and regulatory requirements for patient safety and product integrity has led to the need for advanced supply chain models. Further, the adoption of decentralized trials and direct-to-patient delivery solutions has highlighted the significance of flexible and compliant logistics networks. In addition, increased investment from pharmaceutical and biotech companies has enhanced the demand for efficient packaging, temperature-controlled storage, and distribution services essential for timely trial execution.

Moreover, most clinical trials across various phases have been supported by specialized supply solutions such as cold chain distribution, comparator sourcing, clinical packaging, and return management. Smaller batch distributions with tight timelines have been effectively managed for early-phase studies through adaptable supply models, while large-scale Phase III trials benefit from comprehensive global depot networks. Besides, the expanding pipeline of biologics, biosimilars, and advanced therapies has further boosted the need for ultra-low temperature handling and specialized transportation solutions. As trials broaden in scope and geographical reach, supply and logistics providers have become crucial in ensuring the continuous availability of investigational products. Their role has been vital in fueling market expansion by minimizing delays, ensuring compliance, and enhancing trial efficiency.

Furthermore, established market players are pursuing strategic initiatives, including acquisitions, service expansions, and investments in digital platforms to enhance visibility and tracking. Collaborations with sponsors and contract research organizations (CROs) are being accelerated, focusing on increasing cold chain capacity in the U.S. to address the challenges posed by growing trial complexity. Such factors are expected to drive the market over the estimated timeframe.

U.S. Clinical Trials Supply And Logistics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. clinical trials supply & logistics market report based on service, phase, therapeutic area, and end-use.

• Service Outlook (Revenue, USD Million, 2021 - 2033)
• Logistics & Distribution
• Storage & Retention
• Packaging, Labeling, and Blinding
• Manufacturing
• Comparator Sourcing
• Other Services
• Phase Outlook (Revenue, USD Million, 2021 - 2033)
• Phase I
• Phase II
• Phase III
• Phase IV
• Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• CNS And Mental Disorders
• Others
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceuticals
• Biologicals
• Medical Device

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Service
  • 1.2.2. Phase
  • 1.2.3. Therapeutic Area
  • 1.2.4. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Clinical Trials Supply & Logistics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological Advancements in Supply Chain
    • 3.2.1.2. Increasing R&D Investment by Pharmaceutical and Biopharmaceutical Firms
    • 3.2.1.3. Increasing Demand For Outsourcing Services Across The Developing Economies
    • 3.2.1.4. Expansion of Clinical Trial Sites
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent Regulation Pertaining to Logistics
    • 3.2.2.2. Counterfeiting of Drugs
  • 3.2.3. Market Challenges
  • 3.2.4. Market Opportunities
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis
• 3.5. R&D Spending Analysis (2018-2024)
• 3.6. Clinical Trial Volume Analysis, 2024
• 3.7. Tariff Impact Analysis
• 3.8. Value Chain Analysis
  • 3.8.1. Supply Trends
  • 3.8.2. Demand Trends
• 3.9. Market Analysis Tools
  • 3.9.1. Porter's Five Force Analysis
  • 3.9.2. PESTEL by SWOT Analysis
  • 3.9.3. COVID-19 Impact Analysis

Chapter 4. U.S. Clinical Trials Supply & Logistics Market: Service Estimates & Trend Analysis

• 4.1. U.S. Clinical Trials Supply & Logistics Market, By Service: Segment Dashboard
• 4.2. U.S. Clinical Trials Supply & Logistics Market, By Service: Movement Analysis
• 4.3. U.S. Clinical Trials Supply & Logistics Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
• 4.4. Logistics & Distribution
  • 4.4.1. Logistics & Distribution Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Storage & Retention
  • 4.5.1. Storage & Retention Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Packaging, Labeling, and Blinding
  • 4.6.1. Packaging, Labeling, and Blinding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Manufacturing
  • 4.7.1. Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Comparator Sourcing
  • 4.8.1. Comparator Sourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Other Services
  • 4.9.1. Other Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Clinical Trials Supply & Logistics Market: Phase Estimates & Trend Analysis

• 5.1. U.S. Clinical Trials Supply & Logistics Market, By Phase: Segment Dashboard
• 5.2. U.S. Clinical Trials Supply & Logistics Market, By Phase: Movement Analysis
• 5.3. U.S. Clinical Trials Supply & Logistics Market Estimates & Forecasts, By Phase, 2021 - 2033 (USD Million)
• 5.4. Phase I
  • 5.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Phase II
  • 5.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Phase III
  • 5.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Phase IV
  • 5.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Clinical Trials Supply & Logistics Market: Therapeutic Area Estimates & Trend Analysis

• 6.1. U.S. Clinical Trials Supply & Logistics Market, By Therapeutic Area: Segment Dashboard
• 6.2. U.S. Clinical Trials Supply & Logistics Market, By Therapeutic Area: Movement Analysis
• 6.3. U.S. Clinical Trials Supply & Logistics Market Estimates & Forecasts, By Therapeutic Area, 2021 - 2033 (USD Million)
• 6.4. Oncology
  • 6.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Cardiovascular Diseases
  • 6.5.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Respiratory Diseases
  • 6.6.1. Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. CNS And Mental Disorders
  • 6.7.1. CNS And Mental Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Clinical Trials Supply & Logistics Market: End Use Estimates & Trend Analysis

• 7.1. U.S. Clinical Trials Supply & Logistics Market, By End Use: Segment Dashboard
• 7.2. U.S. Clinical Trials Supply & Logistics Market, By End Use: Movement Analysis
• 7.3. U.S. Clinical Trials Supply & Logistics Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
• 7.4. Pharmaceuticals
  • 7.4.1. Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Biologicals
  • 7.5.1. Biologicals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Medical Device
  • 7.6.1. Medical Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Categorization
• 8.2. Market Position Analysis, 2024 (Heat Map Analysis)
• 8.3. Company Profiles
  • 8.3.1. Thermo Fisher Scientific Inc.
    • 8.3.1.1. Company Overview
    • 8.3.1.2. Financial Performance
    • 8.3.1.3. Service Benchmarking
    • 8.3.1.4. Strategic Initiatives
  • 8.3.2. UPS Healthcare
    • 8.3.2.1. Company Overview
    • 8.3.2.2. Financial Performance
    • 8.3.2.3. Service Benchmarking
    • 8.3.2.4. Strategic Initiatives
  • 8.3.3. Piramal Pharma Solutions
    • 8.3.3.1. Company Overview
    • 8.3.3.2. Financial Performance
    • 8.3.3.3. Service Benchmarking
    • 8.3.3.4. Strategic Initiatives
  • 8.3.4. DHL
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. Parexel International
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Almac Group
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. UDG Healthcare
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Service Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. FedEx
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Service Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Catalent, Inc.
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Service Benchmarking
    • 8.3.9.4. Strategic Initiatives

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 U.S. Clinical Trials Supply & Logistics Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
• Table 4 U.S. Clinical Trials Supply & Logistics Market Estimates and Forecasts, by Phase, 2021 - 2033 (USD Million)
• Table 5 U.S. Clinical Trials Supply & Logistics Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
• Table 6 U.S. Clinical Trials Supply & Logistics Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Market formulation & validation
• Fig. 6 Commodity flow analysis
• Fig. 7 Value-chain-based sizing & forecasting
• Fig. 8 QFD model sizing & forecasting
• Fig. 9 Bottom-up approach
• Fig. 10 Market snapshot
• Fig. 11 Segment snapshot 1
• Fig. 12 Segment snapshot 2
• Fig. 13 Competitive landscape snapshot
• Fig. 14 Parent market outlook, 2024 (USD Billion)
• Fig. 15 Ancillary market outlook, 2024 (USD Billion)
• Fig. 16 U.S. Clinical Trials Supply & Logistics Market Dynamics
• Fig. 17 Porter's five forces analysis
• Fig. 18 PESTEL analysis
• Fig. 19 U.S. Clinical Trials Supply & Logistics Market: Service outlook and key takeaways
• Fig. 20 U.S. Clinical Trials Supply & Logistics Market: Service movement analysis
• Fig. 21 Logistics & Distribution Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Storage & Retention Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Packaging, Labeling, and Blinding Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Manufacturing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 25 Comparator Sourcing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 26 Other Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 27 U.S. Clinical Trials Supply & Logistics Market: Phase outlook and key takeaways
• Fig. 28 U.S. Clinical Trials Supply & Logistics Market: Phase movement analysis
• Fig. 29 Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 30 Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 31 Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 32 Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 33 U.S. Clinical Trials Supply & Logistics Market: Therapeutic Area outlook and key takeaways
• Fig. 34 U.S. Clinical Trials Supply & Logistics Market: Therapeutic Area movement analysis
• Fig. 35 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 36 Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 37 Respiratory Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 38 CNS And Mental Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 39 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 40 U.S. Clinical Trials Supply & Logistics Market: End Use outlook and key takeaways
• Fig. 41 U.S. Clinical Trials Supply & Logistics Market: End Use movement analysis
• Fig. 42 Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 43 Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 44 Biologicals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 45 Medical Device Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• Fig. 46 Key company categorization
• Fig. 47 Service heat map analysis
• Fig. 48 Strategic framework